Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach

被引:427
作者
Lewis, SJG
Foltynie, T
Blackwell, AD
Robbins, TW
Owen, AM
Barker, RA
机构
[1] Univ Cambridge, Cambridge Ctr Brain Repair, Cambridge CB2 1TN, England
[2] Univ Cambridge, Dept Neurol, Cambridge CB2 1TN, England
[3] Univ Cambridge, Dept Psychiat, Cambridge CB2 1TN, England
[4] Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England
[5] MRC, Cognit & Brain Sci Unit, Cambridge, England
基金
英国医学研究理事会;
关键词
D O I
10.1136/jnnp.2003.033530
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To investigate the heterogeneity of idiopathic Parkinson's disease (PD) in a data driven among a cohort of patients in the early clinical stages of the disease meeting established criteria. Methods: Data on demographic, motor, mood, and cognitive measures were collected from consecutive patients in the early stages of PD (Hoehn and Yahr I-III) attending a specialist PD clinic. Statistical cluster analysis of the data allowed the existence of the patient subgroups generated to explored. Results: The analysis revealed four main subgroups: (a) patients with a younger disease onset; (b) a dominant subgroup of patients; (c) a non-tremor dominant subgroup with significant levels of - impairment and mild depression; and (c a subgroup with rapid disease progression but no impairment. Conclusions: This study complements and extends previous research by using a data driven define the clinical heterogeneity of early PD. The approach adopted in this study for the subgroups of patients within Parkinson's disease has important implications for generating hypotheses on defining the heterogeneity of this common condition and its aetiopathological basis thus its treatment.
引用
收藏
页码:343 / 348
页数:6
相关论文
共 70 条
[1]   Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study [J].
Aarsland, D ;
Laake, K ;
Larsen, JP ;
Janvin, C .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2002, 72 (06) :708-712
[2]   Repairing the brain in Parkinson's disease: Where next? [J].
Barker, RA .
MOVEMENT DISORDERS, 2002, 17 (02) :233-241
[3]   AN INVENTORY FOR MEASURING DEPRESSION [J].
BECK, AT ;
ERBAUGH, J ;
WARD, CH ;
MOCK, J ;
MENDELSOHN, M .
ARCHIVES OF GENERAL PSYCHIATRY, 1961, 4 (06) :561-&
[4]   DIFFERENTIAL BEHAVIORAL EFFECTS IN FRONTAL LOBE DISEASE [J].
BENTON, AL .
NEUROPSYCHOLOGIA, 1968, 6 (01) :53-&
[5]  
Brooks DJ, 1999, J NEURAL TRANSM-SUPP, P139
[6]   PARKINSONS-DISEASE AND DEMENTIA - NOREPINEPHRINE AND DOPAMINE IN LOCUS-CERULEUS [J].
CASH, R ;
DENNIS, T ;
LHEUREUX, R ;
RAISMAN, R ;
JAVOYAGID, F ;
SCATTON, B .
NEUROLOGY, 1987, 37 (01) :42-46
[7]   SOME SPECIFIC CLINICAL-FEATURES DIFFERENTIATE MULTIPLE SYSTEM ATROPHY (STRIATONIGRAL VARIETY) FROM PARKINSONS-DISEASE [J].
COLOSIMO, C ;
ALBANES, A ;
HUGHES, AJ ;
DEBRUIN, VMS ;
LEES, AJ .
ARCHIVES OF NEUROLOGY, 1995, 52 (03) :294-298
[8]   Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET [J].
Cools, R ;
Stefanova, E ;
Barker, RA ;
Robbins, TW ;
Owen, AM .
BRAIN, 2002, 125 :584-594
[9]   EFFECT OF AGE AT ONSET ON PROGRESSION AND MORTALITY IN PARKINSONS-DISEASE [J].
DIAMOND, SG ;
MARKHAM, CH ;
HOEHN, MM ;
MCDOWELL, FH ;
MUENTER, MD .
NEUROLOGY, 1989, 39 (09) :1187-1190
[10]   PARKINSONS-DISEASE - THE POSSIBLE RELATIONSHIP OF LATERALITY TO DEMENTIA AND NEUROCHEMICAL FINDINGS [J].
DIRENFELD, LK ;
ALBERT, ML ;
VOLICER, L ;
LANGLAIS, PJ ;
MARQUIS, J ;
KAPLAN, E .
ARCHIVES OF NEUROLOGY, 1984, 41 (09) :935-941